Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 4.54T | 4.65T | 2.81T | 5.31T | 2.21T | 1.92T |
Gross Profit | 2.71T | 2.69T | 2.63T | 2.71T | 2.21T | 1.92T |
EBITDA | 1.70T | 1.68T | 1.79T | 1.76T | 1.05T | 667.09B |
Net Income | 1.28T | 1.25T | 1.37T | 1.45T | 792.92B | 401.63B |
Balance Sheet | ||||||
Total Assets | 53.77T | 52.06T | 55.72T | 55.26T | 51.70T | 46.10T |
Cash, Cash Equivalents and Short-Term Investments | 5.69T | 2.04T | 10.52T | 7.50T | 7.64T | 4.44T |
Total Debt | 12.48T | 9.98T | 10.47T | 10.41T | 10.09T | 9.27T |
Total Liabilities | 48.37T | 45.55T | 49.64T | 50.40T | 47.48T | 42.37T |
Stockholders Equity | 5.40T | 6.50T | 6.08T | 4.86T | 4.22T | 3.73T |
Cash Flow | ||||||
Free Cash Flow | 1.68T | 379.42B | 1.64T | -411.72B | 2.36T | 471.70B |
Operating Cash Flow | 1.74T | 396.64B | 1.73T | -333.58B | 2.43T | 519.65B |
Investing Cash Flow | 2.14T | -58.34B | -346.50B | -72.64B | -2.90T | 209.88B |
Financing Cash Flow | -3.73T | -1.56T | -1.56T | -815.23B | 1.35T | 1.46T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $13.20B | 14.11 | 16.25% | 12.96% | -8.82% | 4.87% | |
76 Outperform | $11.46B | 10.14 | 24.13% | 5.31% | 12.43% | 56.30% | |
73 Outperform | $14.62B | 11.39 | 22.07% | 7.07% | -13.16% | -8.10% | |
72 Outperform | $20.69B | 12.27 | 18.54% | 5.36% | 5.16% | 27.77% | |
70 Outperform | $19.41B | 18.88 | 9.43% | 5.87% | -3.77% | -10.59% | |
68 Neutral | $18.05B | 11.73 | 10.24% | 3.73% | 9.66% | 1.70% | |
66 Neutral | $13.13B | 6.77 | 8.90% | 3.37% | -3.55% | 1.59% |